Literature DB >> 10707112

Cytochrome P450 substrate specificities, substrate structural templates and enzyme active site geometries.

D F Lewis1, M Dickins, P J Eddershaw, M H Tarbit, P S Goldfarb.   

Abstract

The structural characteristics of human cytochrome P450 substrates are outlined in the light of extensive studies on P450 substrate specificity. Templates of superimposed substrates for individual P450 isozymes are shown to fit the corresponding enzyme active sites, where contacts with specific amino acid residues appear to be involved in the interaction with each structural template. Procedures leading to the evaluation of likely P450 specificity, binding affinity and rate of metabolism are described in the context of key examples in which molecular modelling appears to rationalize experimentally observed findings.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10707112     DOI: 10.1515/dmdi.1999.15.1.1

Source DB:  PubMed          Journal:  Drug Metabol Drug Interact        ISSN: 0792-5077


  8 in total

1.  Insights into electron leakage in the reaction cycle of cytochrome P450 BM3 revealed by kinetic modeling and mutagenesis.

Authors:  Joseph B Lim; Kimberly A Barker; Kristen A Eller; Linda Jiang; Veronica Molina; Jessica F Saifee; Hadley D Sikes
Journal:  Protein Sci       Date:  2015-09-09       Impact factor: 6.725

Review 2.  Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges.

Authors:  Collen M Masimirembwa; Ulf Bredberg; Tommy B Andersson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Influence of phenylalanine-481 substitutions on the catalytic activity of cytochrome P450 2D6.

Authors:  G P Hayhurst; J Harlow; J Chowdry; E Gross; E Hilton; M S Lennard; G T Tucker; S W Ellis
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

4.  Metabolism of propafenone and verapamil by cryopreserved human, rat, mouse and dog hepatocytes: comparison with metabolism in vivo.

Authors:  B Reder-Hilz; M Ullrich; M Ringel; N Hewitt; D Utesch; F Oesch; J G Hengstler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-03-04       Impact factor: 3.000

5.  Quantitative structure-activity relationships (QSARs) within the cytochrome P450 system: QSARs describing substrate binding, inhibition and induction of P450s.

Authors:  David F V Lewis
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

Review 6.  Involvement of Ahr Pathway in Toxicity of Aflatoxins and Other Mycotoxins.

Authors:  Francisco Arenas-Huertero; Montserrat Zaragoza-Ojeda; Juana Sánchez-Alarcón; Mirta Milić; Maja Šegvić Klarić; José M Montiel-González; Rafael Valencia-Quintana
Journal:  Front Microbiol       Date:  2019-10-10       Impact factor: 5.640

7.  Cunninghamella as a microbiological model for metabolism of histamine H(3) receptor antagonist 1-[3-(4-tert-butylphenoxy)propyl]piperidine.

Authors:  Elżbieta Pękala; Paulina Kubowicz; Dorota Łażewska
Journal:  Appl Biochem Biotechnol       Date:  2012-09-16       Impact factor: 2.926

8.  Reverse conservation analysis reveals the specificity determining residues of cytochrome P450 family 2 (CYP 2).

Authors:  Tai-Sung Lee
Journal:  Evol Bioinform Online       Date:  2008-02-09       Impact factor: 1.625

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.